| Literature DB >> 34727524 |
Philip J Schluter1,2, Mélissa Généreux3, Kevin Kc Hung4, Elsa Landaverde3, Ronald P Law5, Catherine Pui Yin Mok6, Virginia Murray7, Tracey O'Sullivan8, Zeeshan Qadar9, Mathieu Roy10.
Abstract
BACKGROUND: The COVID-19 pandemic and countries' response measures have had a globally significant mental health impact. This mental health burden has also been fueled by an infodemic: an information overload that includes misinformation and disinformation. Suicide, the worst mental health outcome, is a serious public health problem that can be prevented with timely, evidence-based, and often low-cost interventions. Suicide ideation, one important risk factor for suicide, is thus important to measure and monitor, as are the factors that may impact on it.Entities:
Keywords: COVID-19; age; cross-sectional; epidemiology; gender; infodemic; mental health; misinformation; pandemic; pattern; prevalence; psychosocial impacts; risk; sense of coherence; sociodemographic; suicide; suicide ideation
Mesh:
Year: 2022 PMID: 34727524 PMCID: PMC8765348 DOI: 10.2196/32140
Source DB: PubMed Journal: JMIR Public Health Surveill ISSN: 2369-2960
Names, descriptions, and response options for the considered variables influenced by the pandemic.
| Name | Descriptions | Response options |
| Self-isolation/quarantine | Having experienced self-isolation/quarantine, mandatory or voluntary | Yes because of symptoms or diagnosis of COVID-19, yes for other reasons, no |
| Financial losses | Having experienced financial losses of any kind due to COVID-19 | Yes, no, unsure/ unknown |
| Threat perceived for oneself and/or family | Level of threat posed by the COVID-19 perceived for oneself and/or the family | Very low, low, moderate, high, very high |
| Threat perceived for country and/or world | Level of threat posed by COVID-19 perceived for the country and/or the world | Very low, low, moderate, high, very high |
| Being a victim of stigma | Being a victim of stigma or discrimination due to COVID-19 | Yes, no, decline to answer |
| Level of information about COVID-19 | Level would you rank your level of information about COVID-19 | 10-point scale: 1, very low level; 1-8, otherwise; 9-10, high level; 10, very high level |
| Trust in authorities score | Level at which you would rank your level of trust in (1) scientists, doctors, and health experts; (2) national health organizations; (3) global health organizations; (4) government | Each response rated on a 10-point scale: 1, very low level; 10, very high level; 4 scores summed, and partitioned into approximate quartiles based on measurement wave 1-response distributions |
| Internet-based social media as a regular source of information | Extent that social networks (eg, Facebook, Twitter, Instagram, other networks) are used to inform yourself about COVID-19 | Mainly/always, often, sometimes, not much/never |
| Friends/family/co-workers as a regular source of information | Extent that friends/family/co-workers are used to inform yourself about COVID-19 | Mainly/always, often, sometimes, not much/never |
| Sense of coherence | Measured using the 3-item Sense of Coherence (SOC-3) instrument [ | Each with response options: no (0), yes - sometimes (1), yes - usually (2); question (3) was reverse scored; then, the 3 scores were summed and dichotomized using the threshold: weaker (summed score of 0-4) or stronger (summed score of 5-6). |
Participant numbers and weighted distribution (%) of their demographic characteristics by country and measurement waves 1 (surveyed between May 29, 2020 and June 12, 2020) and 2 (surveyed November 6-18, 2020).
| Country | Gendera, n (%) | Age (years), n (%) | ||||||||
|
| Female | Male | 18-24 | 25-34 | 35-44 | 45-54 | 55-64 | 65-74 | ≥75 | |
|
| ||||||||||
|
| Wave 1 (n=1501) | 723 (48.4) | 772 (51.6) | 163 (10.9) | 247 (16.4) | 243 (16.2) | 269 (17.9) | 262 (17.5) | 246 (16.4) | 72 (4.8) |
|
| Wave 2 (n=2004) | 963 (48.3) | 1031 (51.7) | 218 (10.9) | 329 (16.4) | 324 (16.2) | 359 (17.9) | 350 (17.5) | 340 (17.0) | 84 (4.2) |
|
| ||||||||||
|
| Wave 1 (n=1065) | 516 (48.5) | 548 (51.5) | 59 (5.5) | 226 (21.2) | 191 (17.9) | 204 (19.1) | 189 (17.8) | 146 (13.7) | 50 (4.7) |
|
| Wave 2 (n=1003) | 478 (48.1) | 517 (51.9) | 81 (8.0) | 187 (18.7) | 180 (17.9) | 192 (19.1) | 178 (17.8) | 71 (7.1) | 114 (11.4) |
|
| ||||||||||
|
| Wave 1 (n=1041) | 508 (48.8) | 532 (51.2) | 116 (11.1) | 181 (17.4) | 170 (16.3) | 186 (17.9) | 151 (14.5) | 190 (18.3) | 47 (4.5) |
|
| Wave 2 (n=1000) | 487 (48.8) | 511 (51.2) | 111 (11.1) | 174 (17.4) | 163 (16.3) | 179 (17.9) | 145 (14.5) | 192 (19.2) | 35 (3.5) |
|
| ||||||||||
|
| Wave 1 (n=1015) | 494 (48.6) | 521 (51.4) | 63 (6.2) | 208 (20.5) | 139 (13.7) | 210 (20.7) | 171 (16.9) | 186 (18.3) | 37 (3.7) |
|
| Wave 2 (n=1014) | 489 (48.4) | 520 (51.6) | 57 (5.6) | 215 (21.2) | 118 (11.6) | 228 (22.5) | 161 (15.9) | 197 (19.4) | 38 (3.7) |
|
| ||||||||||
|
| Wave 1 (n=1002) | 478 (47.7) | 523 (52.3) | 95 (9.5) | 144 (14.4) | 138 (13.8) | 177 (17.6) | 239 (23.9) | 160 (16.0) | 48 (4.8) |
|
| Wave 2 (n=1000) | 477 (47.8) | 522 (52.2) | 95 (9.5) | 144 (14.4) | 138 (13.8) | 176 (17.6) | 171 (17.1) | 226 (22.6) | 49 (4.9) |
|
| ||||||||||
|
| Wave 1 (n=1140) | 513 (45.1) | 626 (54.9) | 108 (9.5) | 196 (17.2) | 206 (18.1) | 218 (19.1) | 202 (17.7) | 200 (17.5) | 10 (0.9) |
|
| Wave 2 (n=1002) | 451 (45.0) | 550 (55.0) | 95 (9.5) | 172 (17.2) | 181 (18.1) | 192 (19.1) | 177 (17.7) | 171 (17.1) | 13 (1.3) |
|
| ||||||||||
|
| Wave 1 (n=1041) | 510 (49.4) | 522 (50.6) | 224 (21.6) | 260 (25.0) | 209 (20.1) | 162 (15.5) | 106 (10.2) | 63 (6.1) | 17 (1.6) |
|
| Wave 2 (n=1003) | 489 (49.3) | 503 (50.7) | 216 (21.6) | 251 (25.0) | 201 (20.1) | 156 (15.5) | 126 (12.5) | 47 (4.7) | 6 (0.6) |
|
| ||||||||||
|
| Wave 1 (n=1001) | 484 (48.6) | 512 (51.4) | 122 (12.2) | 184 (18.4) | 163 (16.3) | 175 (17.5) | 157 (15.7) | 149 (14.9) | 50 (5.0) |
|
| Wave 2 (n=1001) | 484 (48.6) | 513 (51.4) | 122 (12.2) | 184 (18.4) | 163 (16.3) | 175 (17.5) | 157 (15.7) | 138 (13.8) | 61 (6.1) |
a25 participants at the measurement wave 1 and 42 participants at measurement wave 2 did not identify as being female (F) or male (M) or preferred not to answer this question, so had their gender set to missing.
Figure 1Age-standardized rates and associated 95% CIs of suicide ideation by country for measurement waves 1 (surveyed between May 29, 2020 and June 12, 2020) and 2 (surveyed November 6-18, 2020).
Figure 2Estimated proportion of participants self-reporting suicide ideation by country and measurement waves 1 and 2 stratified by age group, derived from the binomial regression model including age group, gender, country, measurement wave, and the measurement wave × age group, country × age group, country × gender, and age group × gender interactions. Females are denoted by red, males by blue, measurement wave 1 with hollow circles, and measurement wave 2 with solid circles. BEL: Belgium; CAN: Canada; ENG: England; HK: Hong Kong; NZ: New Zealand; PHL: Philippines; SWI: Switzerland; USA: United States.
Estimated crude and adjusted odds ratios (ORs) and associated 95% CIs of suicide ideation associated with potential risk and protective COVID-19 related factors by measurement wave for the logistic model that included the entire sample over both measurement waves.
| Factors | Crude OR (95% CI)a | Adjusted OR (95% CI)b | |||
|
| Wave 1 | Wave 2 | Wave 1 | Wave 2 | |
|
| |||||
|
| Alone | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
|
| With children | 0.93 (0.78-1.11) | 1.02 (0.85-1.23) | 1.03 (0.83-1.27) | 1.05 (0.85-1.29) |
|
| With others | 0.89 (0.75-1.06) | 0.88 (0.74-1.05) | 0.98 (0.81-1.20) | 0.94 (0.77-1.13) |
|
| |||||
|
| No | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
|
| Yes: health | 1.72 (1.45-2.04) | 1.60 (1.33-1.91) | 1.60 (1.31-1.96) | 1.36 (1.10-1.69) |
|
| Yes: other | 1.43 (1.24-1.65) | 1.32 (1.14-1.52) | 1.29 (1.09-1.53) | 1.22 (1.03-1.44) |
|
| |||||
|
| No | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
|
| Yes: case/symptom-free | 1.16 (1.01-1.32) | 1.42 (1.24-1.63) | 1.08 (0.93-1.26) | 1.23 (1.05-1.44) |
|
| Yes: case or symptoms | 3.16 (2.64-3.77) | 2.84 (2.42-3.34) | 2.39 (1.95-2.93) | 1.91 (1.58-2.32) |
|
| |||||
|
| No | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
|
| Yes | 1.39 (1.23-1.57) | 1.82 (1.62-2.06) | 1.09 (0.95-1.25) | 1.40 (1.22-1.60) |
|
| Unsure/unknown | 1.95 (1.56-2.43) | 2.85 (2.15-3.78) | 1.79 (1.30-2.47) | 2.42 (1.50-3.91) |
|
| |||||
|
| High | 1.84 (1.64-2.07) | 1.47 (1.31-1.66) | 1.66 (1.44-1.90) | 1.31 (1.14-1.51) |
|
| Otherwise | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
|
| |||||
|
| High | 1.00 (0.88-1.13) | 0.91 (0.80-1.04) | 0.85 (0.73-0.98) | 0.82 (0.70-0.96) |
|
| Otherwise | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
|
| |||||
|
| No | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
|
| Yes | 3.34 (2.88-3.87) | 3.83 (3.27-4.49) | 2.58 (2.17-3.06) | 2.74 (2.26-3.31) |
|
| Decline to answer | 1.64 (1.37-1.95) | 2.24 (1.73-2.89) | 1.15 (0.90-1.45) | 1.23 (0.78-1.95) |
|
| |||||
|
| High | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
|
| Otherwise | 0.96 (0.85-1.08) | 0.98 (0.86-1.11) | 0.91 (0.79-1.06) | 0.97 (0.83-1.13) |
|
| |||||
|
| Q1 (low) | 1.39 (1.19-1.63) | 1.39 (1.19-1.63) | 1.56 (1.29-1.89) | 1.40 (1.15-1.71) |
|
| Q2 | 1.15 (0.98-1.36) | 1.27 (1.08-1.50) | 1.29 (1.06-1.57) | 1.34 (1.10-1.63) |
|
| Q3 | 0.96 (0.81-1.13) | 1.11 (0.95-1.31) | 1.06 (0.87-1.28) | 1.09 (0.90-1.32) |
|
| Q4 (high) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
|
| |||||
|
| Often/always | 1.35 (1.19-1.52) | 1.54 (1.35-1.75) | 1.11 (0.96-1.30) | 1.47 (1.25-1.72) |
|
| Sometimes/never | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
|
| |||||
|
| Often/always | 1.23 (1.10-1.38) | 1.14 (1.01-1.28) | 1.06 (0.92-1.23) | 0.96 (0.83-1.11) |
|
| Sometimes/never | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
|
| |||||
|
| Stronger (5-6) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
|
| Weaker (0-4) | 3.96 (3.36-4.67) | 4.56 (3.85-5.40) | 3.80 (3.18-4.55) | 4.39 (3.66-5.27) |
aAdjusted for gender, age group, country, measurement wave, age group × gender, country × gender, age group × country, and age group × measurement wave.
bAdjusted for all variables included within this table, together with their interaction by measurement wave and the main effect and interactions terms included within the crude analysis.